The impact of herpes zoster and post-herpetic neuralgia on quality of life: Patient-reported outcomes in six European countries

Journal of Public Health (Germany)

Volumn 20, Issue 4, 2012, Pages 441-451

  Lukas, Kati ^a   Edte, Alexander ^b,c   Bertrand, Isabelle ^a  

^a SANOFI PASTEUR   (France)

^b Synovate GmbH   (Germany)

^c TNS Healthcare GmbH   (Germany)

Author keywords

Europe; Herpes zoster; Pain; Post herpetic neuralgia; Quality of life

Indexed keywords

ABSENTEEISM; ADL DISABILITY; ADULT; ANALGESIA; ANXIETY; ARTICLE; BELGIUM; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEPRESSION; DISEASE SURVEILLANCE; EUROPEAN UNION; FAMILY RELATION; FEMALE; HEALTH STATUS; HERPES ZOSTER; HUMAN; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PORTUGAL; POSTHERPETIC NEURALGIA; QUALITY OF LIFE; SCREENING; SLEEP DISORDER; SOCIAL LIFE; SPAIN; SWEDEN; SWITZERLAND; WALKING DIFFICULTY;

EID: 84863989075     PISSN: 09431853     EISSN: 16132238     Source Type: Journal    
DOI: 10.1007/s10389-011-0481-8     Document Type: Article

References (45)

1. Arvin A (2005) Aging, immunity, and the varicella-zoster virus. N Engl J Med 352:2266-2267
2. Banks S, Dinges DF (2007) Behavioral and physiological consequences of sleep restriction. J Clin Sleep Med 3:519-528
3. Brisson M, Edmunds WJ, Law B, Gay NJ, Walld R, Brownell M, Roos L, De Serres G (2001) Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 127:305-314
4. Coplan PM, Schmader K, Nikas A, Chan IS, Choo P, Levin MJ, Johnson G, Bauer M, Williams HM, Kaplan KM, Guess HA, Oxman MN (2004) Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain 5:344-356
5. Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, Patrick D, Blanchette C, Mansi JA (2010) The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. Can Med Assoc J 182:1731-1736
6. Dworkin RH (2006) Post-herpetic neuralgia. Herpes 13(Suppl 1):21A-27A
7. Dworkin RH, Gnann JW Jr, Oaklander AL, Raja SN, Schmader KE, Whitley RJ (2008) Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain 9(Suppl 1):S37-S44
8. Fillingim RB (2005) Individual differences in pain responses. Curr Rheumatol Rep 7:342-347
9. Gauthier A, Breuer J, Carrington D, Martin M, Rémy V (2009) Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 137:38-47
10. Gialloreti LE, Merito M, Pezzotti P, Naldi L, Gatti A, Beillat M, Serradell L, di Marzo R, Volpi A (2010) Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis 10:230
11. Hernandez A, Sachs-Ericsson N (2006) Ethnic differences in pain reports and the moderating role of depression in a community sample of Hispanic and Caucasian participants with serious health problems. Psychosom Med 68:121-128
12. Hope-Simpson RE (1965) The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 58:9-20
13. Hope-Simpson RE (1975) Postherpetic neuralgia. J R Coll Gen Pract 25:571-575
14. Irwin M, Costlow C, Williams H, Artin KH, Chan CY, Stinson DL, Levin MJ, Hayward AR, Oxman MN (1998) Cellular immunity to varicella-zoster virus in patients with major depression. J Infect Dis 178(Suppl 1):S104-108.
15. [Erratum in: J Infect Dis 1999, 179:753]
16. Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T, Zoster Quality-of-Life (ZQoL) Expert Group (2010) The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 8:37
17. Johnson RW, Wasner G, Saddier P, Baron R (2007) Postherpetic neuralgia: epidemiology, pathophysiology and management. Expert Rev Neurother 7:1581-1595
18. Katz J, Melzack R (1999) Measurement of pain. Surg Clin North Am 79:231-252
19. Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH (2004) Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 39:342-348
20. Levin MJ, Murray M, Rotbart HA, Zerbe GO, White CJ, Hayward AR (1992) Immune response of elderly individuals to a live attenuated varicella vaccine. J Infect Dis 166:253-259
21. Levin MJ, Barber D, Goldblatt E, Jones M, LaFleur B, Chan C, Stinson D, Zerbe GO, Hayward AR (1998) Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis 178(Suppl 1):S109-S112
22. Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJ, Caulfield MJ (2003) Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis 188:1336-1344
23. Levin MJ, Oxman MN, Zhang JH, Johnson GR, Stanley H, Hayward AR, Caulfield MJ, Irwin MR, Smith JG, Clair J, Chan IS, Williams H, Harbecke R, Marchese R, Straus SE, Gershon A, Weinberg A, Veterans Affairs Cooperative Studies Program Shingles Prevention Study Investigators (2008) Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis 197:825-835
24. Livengood JM (2000) The role of stress in the development of herpes zoster and postherpetic neuralgia. Curr Rev Pain 4:7-11
25. Lungu O, Annunziato PW, Gershon A, Staugaitis SM, Josefson D, LaRussa P, Silverstein SJ (1995) Reactivated and latent varicellazoster virus in human dorsal root ganglia. Proc Natl Acad Sci USA 92:10980-10984
26. Lydick E, Epstein RS, Himmelberger D, White CJ (1995) Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology 45(12 Suppl 8):S52-S53
27. Oster G, Harding G, Dukes E, Edelsberg J, Cleary PD (2005) Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain 6:356-363
28. Oxman MN (1995) Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology 45(12 Suppl 8):S41-S46
29. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL; Shingles Prevention Study Group (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352:2271-2284
30. Oxman MN, Levin MJ; Shingles Prevention Study Group (2008) Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis 197(Suppl 2):S228-S236
31. Rosekind MR, Gregory KB, Mallis MM, Brandt SL, Seal B, Lerner D (2010) The cost of poor sleep: workplace productivity loss and associated costs. J Occup Environ Med 52:91-98
32. Schmader K (2001) Herpes zoster in older adults. Clin Infect Dis 32:1481-1486
33. Schmader K, Gnann JW Jr, Watson CP (2008) The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis 197(Suppl 2):S207-S215
34. Schmader KE (2002) Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 18:350-354
35. Schmader KE, Sloane R, Pieper C, Coplan PM, Nikas A, Saddier P, Chan IS, Choo P, Levin MJ, Johnson G, Williams HM, Oxman MN (2007) The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain 23:490-496
36. Schmader KE, Johnson GR, Saddier P, Ciarleglio M, Wang WW, Zhang JH, Chan IS, Yeh SS, Levin MJ, Harbecke RM, Oxman MN; Shingles Prevention Study Group (2010) Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults. J Am Geriatr Soc 58:1634-1641
37. Scott FT, Leedham-Green ME, Barrett-Muir WY, Hawrami K, Gallagher WJ, Johnson R, Breuer J (2003) A study of shingles and the development of postherpetic neuralgia in East London. J Med Virol 70(Suppl 1):S24-S30
38. Thomas SL, Hall AJ (2004) What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 4:26-33
39. Trannoy E, Berger R, Holländer G, Bailleux F, Heimendinger P, Vuillier D, Creusvaux H (2000) Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial. Vaccine 18:1700-1706
40. van Seventer R, Sadosky A, Lucero M, Dukes E (2006) A crosssectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia. Age Ageing 35:132-137
41. Vlaar AP, ten Klooster PM, Taal E, Gheith RE, El-Garf AK, Rasker JJ, van de Laar MA (2007) A cross-cultural study of pain intensity in Egyptian and Dutch women with rheumatoid arthritis. J Pain 8:730-736
42. Weinke T, Edte A, Schmitt S, Lukas K (2010) Impact of herpes zoster and post-herpetic neuralgia on patients' quality of life: a patientreported outcomes survey. J Public Health 18:367-374
43. Yawn BP, Saddier P, Wollan PC, StSauver JL, Kurland MJ, Sy LS (2007) A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 82:1341-1349
44. [Erratum in: Mayo Clin Proc 2008;83:255]
45. ® SmPC (2006) Available at: http://www.ema.europa. eu/docs/en-GB/document-library/EPAR-Product-Information/human/000674/ WC500053462.pdf. Cited 25 May 2011